CRISPR/$CRSP
About CRISPR
Ticker
Industry
Headquarters
Employees
CRISPR Metrics
$3.3B
-
-$2.90
1.66
-
Price and volume
Market cap
$3.3B
Beta
1.66
52-week high
$91.10
52-week low
$36.52
Average daily volume
1.8M
Financial strength
Current ratio
21.644
Quick ratio
21.553
Long term debt to equity
10.861
Total debt to equity
11.731
Management effectiveness
Return on assets (TTM)
-9.57%
Return on equity (TTM)
-13.07%
Valuation
Price to revenue (TTM)
15.881
Price to book
1.71
Price to tangible book (TTM)
1.71
Price to free cash flow (TTM)
-16.847
Growth
Revenue change (TTM)
19.31%
Earnings per share change (TTM)
-35.36%
3-year revenue growth (CAGR)
-39.20%
3-year earnings per share growth (CAGR)
-18.04%
What the Analysts think about CRISPR
Analyst Ratings
CRISPR Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
CRISPR Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
CRISPR News
CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)
CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025
FAQs
What’s the current market cap for CRISPR stock?
What is the P/E ratio for CRISPR stock?
Does CRISPR stock pay dividends?
No, CRISPR (CRSP) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next CRISPR dividend payment date?
CRISPR (CRSP) stock does not pay dividends to its shareholders.
What is the beta indicator for CRISPR?
CRISPR (CRSP) has a beta rating of 1.66. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.